Why is there little market confidence in Biovaxys?Does this extraordinarily erradic trading volume and share price instability exist due to lack of confidence or trust in management?
Definitely the Cease Trade Order in May pointed to weak administrative practices, but were other factors also in play?
What is necessary to confirm Biovaxys's future is positive and shareholders can anticipate professional management going forward?